Results
1 -
10 of
70
(Click
here to explore results)
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 7 Protein Phosphatases in Parkinson’s Disease. Petr Heneberg
, 2013
, Pages 149-171
- Oxidative Stress and Redox Signalling in Parkinson’s Disease, Subject Index
, 2017
, Pages 505-520
- Oxidative Stress and Redox Signalling in Parkinson’s Disease, CHAPTER 7 Neuroinflammation and Oxidative Stress in Models of Parkinson’s Disease and Protein-Misfolding Disorders. Ronald B. Tjalkens, Karin M. Streifel, Julie A. Moreno
, 2017
, Pages 184-209
- Allosterism in Drug Discovery, CHAPTER 10 mGlu4 PET Ligands as Enablers of Target Biology Understanding. Zhaoda Zhang, Pekka Poutiainen, Anna-Liisa Brownell
, 2017
, Pages 220-246
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 14 Tryptophan Metabolism in Parkinson’s Disease: Future Therapeutic Possibilities. Zsófia Majláth, László Vécsei
, 2013
, Pages 327-340
- Nuclear Magnetic Resonance: Volume 44, NMR in living systems. M. J. W. Prior
, 2015
, Volume 44
, Pages 507-546
- Nuclear Magnetic Resonance: Volume 43, Chapter 13 NMR in living systems. M. J. W. Prior
, 2014
, Volume 43
, Pages 495-550
- Berries and Berry Bioactive Compounds in Promoting Health, Chapter 8 Neuroprotective Mechanisms of Berry Bioavailable Polyphenol Metabolites. Natasa Loncarevic-Vasiljkovic, Diogo Carregosa, Cláudia Nunes dos Santos
, 2022
, Pages 208-245
- Oxidative Stress and Redox Signalling in Parkinson’s Disease, Contents
, 2017
, Pages P009-P016
- Handbook of Antioxidant Methodology: Approaches to Activity Determination, Chapter 10 Antioxidant Activity and the Role of Gene and Protein Expression in Oxidative Stress. Doaa M. Hanafy, Rodney A. Hill
, 2021
, Pages 310-362